Champions Oncology
CSBR
CSBR
14 hedge funds and large institutions have $16.2M invested in Champions Oncology in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
14
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$82.1K | |
| 2 | +$54.7K | |
| 3 | +$18K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10K |
Top Sellers
| 1 | -$82K | |
| 2 | -$62K | |
| 3 | -$30.5K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$10.8K |
| 5 |
JPMorgan Chase & Co
New York
|
-$10K |